Amino acid composition of α1/α2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation

被引:41
作者
Barel, MT
Pizzato, N
van Leeuwen, D
Le Bouteiller, P
Wiertz, EJHJ
Lenfant, F
机构
[1] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands
[2] Hop Purpan, CPTP, INSERM, U563, Toulouse, France
关键词
human cytomegalovirus; US11; HLA-G; MHC class I; down-regulation;
D O I
10.1002/eji.200323912
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During co-evolution with its host, human cytomegalovirus has acquired multiple defense mechanisms to escape from immune recognition. In this study, we focused on US11, which binds to MHC class I heavy chains and mediates their dislocation to the cytosol and subsequent degradation by proteasomes. To examine which domains of class I heavy chains are involved in this process, we constructed chimeric HLA molecules of US11-sensitive and -insensitive class I molecules (HLA-A2 and HLA-G, respectively). Pulse-chase experiments were performed to evaluate protein stability and interactions between class I heavy chains and US11. Flow cytometry was employed to assess the effect of US11 on surface expression of the different chimeras. Our results indicate that the alpha1 and alpha2 domains of HLA molecules are important for the affinity of US11 association. However, the degradation efficiency seems to rely mostly on cytosolic tail residues. We found that the nonclassical HLA-G molecule is insensitive to US11-mediated degradation solely because it lacks essential tail residues. A deletion of the last two tail residues in full-length MHC class I molecules already caused a severe reduction in degradation efficiency. Altogether, our data provide new insights into the mechanism by which US11 down-regulates MHC class I molecules.
引用
收藏
页码:1707 / 1716
页数:10
相关论文
共 30 条
  • [1] AIYAR A, 1993, BIOTECHNIQUES, V14, P366
  • [2] Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8+ T cells
    Basta, S
    Chen, WS
    Bennink, JR
    Yewdell, JW
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (11) : 5403 - 5408
  • [3] Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G
    Blaschitz, A
    Lenfant, F
    Mallet, V
    Hartmann, M
    Bensussan, A
    Geraghty, DE
    Le Bouteiller, P
    Dohr, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3380 - 3388
  • [4] The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
    Cohen, GB
    Gandhi, RT
    Davis, DM
    Mandelboim, O
    Chen, BK
    Strominger, JL
    Baltimore, D
    [J]. IMMUNITY, 1999, 10 (06) : 661 - 671
  • [5] ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
    Cosman, D
    Müllberg, J
    Sutherland, CL
    Chin, W
    Armitage, R
    Fanslow, W
    Kubin, M
    Chalupny, NJ
    [J]. IMMUNITY, 2001, 14 (02) : 123 - 133
  • [6] Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes
    Dardalhon, V
    Noraz, N
    Pollok, K
    Rebouissou, C
    Boyer, M
    Bakker, AQ
    Spits, H
    Taylor, N
    [J]. HUMAN GENE THERAPY, 1999, 10 (01) : 5 - 14
  • [7] NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation
    Falk, CS
    Mach, M
    Schendel, DJ
    Weiss, EH
    Hilgert, I
    Hahn, G
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (06) : 3257 - 3266
  • [8] FERRIER P, 1985, J IMMUNOL, V135, P1281
  • [9] The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules
    Furman, MH
    Dey, N
    Tortorella, D
    Ploegh, HL
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (22) : 11753 - 11756
  • [10] Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface?
    Furman, MH
    Ploegh, HL
    Schust, DJ
    [J]. HUMAN IMMUNOLOGY, 2000, 61 (11) : 1169 - 1176